Alaunos Therapeutics analyst ratings
Alaunos Therapeutics analyst ratings
While ratings are subjective and will change, the latest Alaunos Therapeutics (TCRT) rating was a with a price target of $0.00 to $3.00. The current price Alaunos Therapeutics (TCRT) is trading at is $1.40, which is within the analyst's predicted range.| Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
|---|---|---|---|---|---|
| 07/15/2022 | 114.29% | Cantor Fitzgerald | → $3 | Assumes | → Overweight |
| 05/04/2022 | 114.29% | Wells Fargo | → $3 | Upgrades | Equal-Weight → Overweight |
| 日期 | 上行/下行 | 分析公司 | 目標價格變動 | 評級變動 | 之前/當前的評級 |
|---|---|---|---|---|---|
| 07/15/2022 | 114.29% | 坎託·菲茨傑拉德 | → 3 美元 | 假設 | → 超重 |
| 05/04/2022 | 114.29% | 富國銀行 | → 3 美元 | 升級 | 重量相等 → 超重 |
Alaunos Therapeutics Questions & Answers
Alaunos Therapeutics 問題與解答
The latest price target for Alaunos Therapeutics (NASDAQ: TCRT) was reported by Cantor Fitzgerald on July 15, 2022. The analyst firm set a price target for $3.00 expecting TCRT to rise to within 12 months (a possible 114.29% upside). 2 analyst firms have reported ratings in the last year.
坎託·菲茨傑拉德於2022年7月15日公佈了Alaunos Therapeutics（納斯達克股票代碼：TCRT）的最新目標股價。該分析公司將目標股價定爲3.00美元，預計TCRT將在12個月內升至12個月內（可能上漲114.29％）。去年有兩家分析公司公佈了評級。
The latest analyst rating for Alaunos Therapeutics (NASDAQ: TCRT) was provided by Cantor Fitzgerald, and Alaunos Therapeutics their overweight rating.
坎託·菲茨傑拉德對Alaunos Therapeutics（納斯達克股票代碼：TCRT）的最新分析師評級由坎託·菲茨傑拉德提供，而Alaunos Therapeutics則提供了增持評級。
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Alaunos Therapeutics, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Alaunos Therapeutics was filed on July 15, 2022 so you should expect the next rating to be made available sometime around July 15, 2023.
分析師在進行了廣泛的研究後得出了股票評級，其中包括瀏覽公開財務報表，與Alaunos Therapeutics的高管和客戶交談，以及聽取業績電話會議。大多數分析師每三個月做一次這樣的評級，因此每家公司每年應該獲得4次評級。Alaunos Therapeutics的最新評級是在2022年7月15日公佈的，因此您應該預計下一個評級將在2023年7月15日左右公佈。
While ratings are subjective and will change, the latest Alaunos Therapeutics (TCRT) rating was a with a price target of $0.00 to $3.00. The current price Alaunos Therapeutics (TCRT) is trading at is $1.40, which is within the analyst's predicted range.
儘管評級是主觀的，並且會發生變化，但最新的Alaunos Therapeutics（TCRT）評級爲A，目標股價爲0.00美元至3.00美元。Alaunos Therapeutics（TCRT）目前的交易價格爲1.40美元，在分析師的預測區間內。
